NCT06608160View on ClinicalTrials.gov

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 20, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
PET / CTLung CarcinomaImmunotherapy
Trial Locations (1)

200000

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
lead

Ruijin Hospital

OTHER